Results 241 to 250 of about 296,267 (307)

New parajeilongviruses detected in bats but not in humans: assays for screening and diagnostic purposes. [PDF]

Arch Virol
Pulkkinen E, Jackson R, Joensuu R, Korhonen EM, Masika MM, Anzala O, Ogola JG, Webala PW, Lunn TJ, Forbes KM, Vapalahti O, Kinnunen T, Sironen T, Jääskeläinen AJ.   +13 more
europepmc   +1 more source

Real‐World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry

United European Gastroenterology Journal, Volume 14, Issue 4, May 2026.
ABSTRACT Background Upadacitinib (UPA) is the first oral Janus kinase (JAK) inhibitor approved for the treatment of Crohn's disease (CD). Real‐world data, particularly from large nationwide cohorts, remain limited. This study aimed to evaluate the real‐world effectiveness, safety, and treatment persistence of UPA in patients with CD.
M. Iborra, B. Botella, M. D. Martín‐Arranz, D. Ceballos, C. Martínez‐Pascual, A. Garrido, P. Varela, M. Moreta, E. Brunet‐Mas, Y. González‐Lama, E. Rodríguez‐González, M. Vicuña, J. P. Gisbert, I. Ordás, F. Argüelles‐Arias, J. Tosca‐Cuquerella, R. Vicente‐Lidón, M. Sierra‐Ausín, I. Rodríguez‐Lago, D. Martín‐Rodríguez, J. M. Paredes, B. Sicilia, I. García de la Filia, N. Jiménez, M. Barreiro‐de Acosta, E. Betoré, I. Ferrer‐Bradley, L. García‐Alles, J. M. Huguet, S. Castellet‐Farrús, M. J. García, A. Gutiérrez‐Casbas, Á. Ponferrada‐Díaz, L. Ramos, M. Calafat, I. Vera, C. Suárez‐Ferrer, E. Fernández‐Velado, S. Rodríguez‐Sánchez, A. Mínguez, A. Mancebo, J. Barrio, S. Lario, D. R. de La Cruz, Alejandro Hernández‐Camba, C. Rodríguez‐Gutiérrez, M. Chaparro, E. Ricart, L. Almenara‐Michelena, A. Balaguer, E. Domènech, P. Nos   +51 more
wiley   +1 more source

Ocular manifestations of primary thrombotic microangiopathies : a descriptive systematic review. [PDF]

BMC Ophthalmol
Baker M, Ayoub M, Ghosheh T, Alnajjar Z, Alkhawaldeh M, Al-Rashdan Y, Aldabaibeh D, Al-Shami K, Karaja S.   +8 more
europepmc   +1 more source

Factors Governing the Cross-Species Virulence of Shiga Toxin-Producing <i>Escherichia coli</i>. [PDF]

Pathogens
Hart P, Bowitch A, Mellmann A, Ferkey DM, Koudelka GB.   +4 more
europepmc   +1 more source

Predicting clinical outcome of <i>Escherichia coli</i> O157:H7 infections using explainable machine learning. [PDF]

Microb Genom
Paganini JA, Khatun S, McAteer S, Cowley L, Greig DR, Gally DL, Jenkins C, Dallman TJ.   +7 more
europepmc   +1 more source

Enterohemorrhagic <i>Escherichia coli</i> O157 outer membrane vesicles administered by oral gavage cause renal tubular injury and acute kidney failure in mice. [PDF]

Front Cell Infect Microbiol
Háček J, Vlková A, Krsek D, Kolařík L, Spálenková A, Sychra T, Tesařová T, Gayibov E, Václavíková R, Zieg J, Bielaszewska M.   +10 more
europepmc   +1 more source

Commentary: Complement genetic variants and FH desialylation in <i>S. pneumoniae</i>-haemolytic uraemic syndrome. [PDF]

Front Immunol
Baas LM, van de Kar NCAJ, Michels MAHM, van den Heuvel LP.   +3 more
europepmc   +1 more source

Pathogenic potential and phylogenomic analysis of <i>stx2</i>-carrying O26:H11 Shiga toxin-producing <i>Escherichia coli</i> isolated from dairy products in France (2014-2024). [PDF]

Microb Genom
Soleau N, Bruto M, Ganet S, Bonacorsi S, Cointe A, Sergentet D.   +5 more
europepmc   +1 more source

HUS

, 2016
openaire   +1 more source